
Sign up to save your podcasts
Or


International expert faculty discuss how sodium-glucose cotransporter-2 (SGLT2) inhibitors have changed the management of patients with heart failure (HF). Credit available for this activity expires: [06/24/23]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976002?src=mkm_podcast_addon_976002
Can anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help.
Credit available for this activity expires: 6/23/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535
With incidence of food-induced anaphylaxis on the increase, are you up to date on how best to diagnose and manage patients with food allergies?
Credit available for this activity expires: 6/21/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975719?src=mkm_podcast_addon_975719
Do you know the best imaging modalities to diagnose advanced age-related macular degeneration (AMD) and track its progress? Learn how to assess patients and how to discuss with them what the future may hold.
Credit available for this activity expires: 6/17/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975758?src=mkm_podcast_addon_975758
Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?
Credit available for this activity expires: 6/20/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726
Patients with extensive-stage small cell lung cancer (ES-SCLC) have a 10-month survival of 10 months following standard frontline chemotherapy. Join the experts in discussing immune checkpoint inhibitors (ICIs) in patients with SCLC.
Credit available for this activity expires: 6/15/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975532?src=mkm_podcast_addon_975532
Do you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)?
Credit available for this activity expires: 6/14/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383
What do the latest guidelines say about HF management? Drs Butler, Bozkurt, and McDonagh discuss.
Credit available for this activity expires: 6/13/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975310?src=mkm_podcast_addon_975310
Do you know how and when to screen for depression in people with epilepsy, and when to manage depression and when to refer?
Credit available for this activity expires: 6/10/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975275?src=mkm_podcast_addon_975275
Did you know that estrogen receptor-positive breast cancer often develops treatment resistance to endocrine therapy?
Credit available for this activity expires: 5/31/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974726?src=mkm_podcast_addon_974726
From the publisher's feed

1,262 Listeners

318 Listeners

499 Listeners

298 Listeners

1,388 Listeners

149 Listeners

893 Listeners

13 Listeners

16 Listeners

291 Listeners

3,347 Listeners

7,999 Listeners

195 Listeners

520 Listeners

371 Listeners

60 Listeners

26 Listeners

430 Listeners